Analysis of pp60c‐src tyrosine kinase activity and phosphotyrosyl phosphatase activity in human colon carcinoma and normal human colon mucosal cells

We have compared the level of phosphotyrosyl phosphatase activity in lysates from normal human colon mucosal cells and human colon carcinoma cells and analyzed the effect of incubating these cells with sodium orthovanadate, an inhibitor of phosphotyrosyl phosphatase activity, on the relative abundance of acid‐stable phosphotyrosine and on in vitro protein kinase activity of pp60c‐src. Additionally, we compared the effect of lysing these cells in buffer containing only nonionic detergents with RIPA buffer, which contains both sodium dodecyl sulfate and deoxycholate, on the in vitro kinase activity of pp60c‐src. Our results show that the level of detectable phosphotyrosyl phosphatase activity in lysates derived from normal colon cells and colon carcinoma cells is very similar. Additionally, the abundance of acid‐stable phosphotyrosine in these cells cultured in the absence or presence of vanadate is not significantly different. However, incubation of these cells with vanadate significantly stimulates the activity of pp60c‐src derived from the normal colon cells in immune‐complex kinase assays, while having no detectable effect on the activity of pp60c‐src from the colon tumor cells. The in vitro protein kinase activity of pp60c‐src derived from RIPA buffer lysates of colon carcinoma cells was found to be elevated five‐ to sevenfold when compared with pp60c‐src from these same cells lysed in buffer containing only Nonidet‐P 40 as a detergent. The type of lysis buffer did not effect the activity of pp60c‐src from normal colon mucosal cells. These results provide additional evidence that the activity of pp60c‐src may be regulated differently in colon carcinoma and normal colon mucosal cells.

[1]  N. Rosen,et al.  Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells. , 1987, Oncogene research.

[2]  T. Kmiecik,et al.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation , 1987, Cell.

[3]  C. Cartwright,et al.  Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain , 1987, Cell.

[4]  T. Roberts,et al.  Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src , 1987, Cell.

[5]  N. Rosen,et al.  Activation of pp60c-src protein kinase activity in human colon carcinoma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Cooper,et al.  Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src , 1986, Molecular and cellular biology.

[7]  H. Iba,et al.  Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein , 1986, Molecular and cellular biology.

[8]  P. Cohen,et al.  Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. , 1986, The Journal of biological chemistry.

[9]  J. Browning,et al.  Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase , 1986, Cell.

[10]  T. Hunter,et al.  The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats , 1986, Cell.

[11]  N. Johnsson,et al.  Repeating sequence homologies in the p36 target protein of retroviral protein kinases and lipocortin the p37 inhibitor of phospholipase A2 , 1986, FEBS letters.

[12]  H. Iba,et al.  Activation of the transforming potential of p60c-src by a single amino acid change. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Jonathan A. Cooper,et al.  Tyr527 is phosphorylated in pp60c-src: implications for regulation. , 1986, Science.

[14]  Jonathan A. Cooper,et al.  Restriction of the in vitro and in vivo tyrosine protein kinase activities of pp60c-src relative to pp60v-src , 1985, Molecular and cellular biology.

[15]  S. Courtneidge Activation of the pp60c‐src kinase by middle T antigen binding or by dephosphorylation. , 1985, The EMBO journal.

[16]  F. Cross,et al.  Low level of cellular protein phosphorylation by nontransforming overproduced p60c-src , 1985, Molecular and cellular biology.

[17]  T. Hunter Protein-Tryosine Kinases , 1985 .

[18]  M. Israel,et al.  In vitro association and phosphorylation of polyoma virus middle T antigen by cellular tyrosyl kinase activity. , 1984, The Journal of biological chemistry.

[19]  J. Parsons,et al.  Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin , 1984, Journal of virology.

[20]  P. Branton,et al.  Identification, purification, and characterization of phosphotyrosine-specific protein phosphatases from cultured chicken embryo fibroblasts , 1984, Molecular and cellular biology.

[21]  J. Brugge,et al.  Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses , 1983, Journal of virology.

[22]  R. Erikson,et al.  Separation of multiple phosphotyrosyl-and phosphoseryl-protein phosphatases from chicken brain. , 1983, The Journal of biological chemistry.

[23]  Jonathan A. Cooper,et al.  Analysis of the sequence of amino acids surrounding sites of tyrosine phosphorylation. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Oppermann,et al.  Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Bornstein,et al.  Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn. , 1981, The Journal of biological chemistry.

[26]  Tony Hunter,et al.  Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus , 1980, Cell.